Literature DB >> 3335460

Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG Study.

H G Seydel1, L Leichman, R Byhardt, J Cooper, A Herskovic, J Libnock, R Pazdur, J Speyer, J Tschan.   

Abstract

Forty-one evaluable patients with localized squamous cell carcinoma of the thoracic esophagus were treated by a course of radiation therapy (3000 cGy in 3 weeks), 5-Fluorouracil (5-FU) and Cis-platinum (Pt). This was followed by an esophagectomy in medically eligible patients who agreed to the procedure and who had no evidence of extrathoracic tumor. If tumor was found in the specimen, an added 2000 cGy of radiation therapy and additional 5-FU and Pt were given. One-year survival was 44%, 2-year survival 15%, and 3-year survival 8%. All 3-year survivors had tumor-free specimens, but one patient with tumor in the thorax and subdiaphragmatic metastasis survived 2 years.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335460     DOI: 10.1016/0360-3016(88)90047-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Role of radiotherapy in the pre-operative management of carcinoma of the esophagus.

Authors:  Bryan H Burmeister
Journal:  World J Gastrointest Oncol       Date:  2015-01-15

2.  Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus.

Authors:  Abhinav Dewan; S K Sharma; A K Dewan; Ruparna Khurana; Manoj Gupta; Anjali Pahuja; Himanshu Srivastava; Rupal Sinha
Journal:  J Gastrointest Cancer       Date:  2017-03

Review 3.  Transhiatal esophagectomy for treatment of benign and malignant esophageal disease.

Authors:  M B Orringer; B Marshall; M D Iannettoni
Journal:  World J Surg       Date:  2001-02       Impact factor: 3.352

Review 4.  [Radiotherapy in the multimodal treatment of esophageal carcinoma. A review].

Authors:  P Fritz; M Wannenmacher
Journal:  Strahlenther Onkol       Date:  1997-06       Impact factor: 4.033

5.  A randomized comparison of dilatation alone versus dilatation plus laser in patients receiving chemotherapy and external beam radiation for esophageal carcinoma.

Authors:  B S Anand; Z A Saeed; P A Michaletz; C B Winchester; M A Doherty; J H Liem; D Y Graham
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

6.  Preoperative high-dose radiation and chemotherapy in adenocarcinoma of the esophagus and esophagogastric junction.

Authors:  E R Sauter; L R Coia; S M Keller
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

7.  The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus.

Authors:  F G Duhaylongsod; M R Gottfried; J D Iglehart; A L Vaughn; W G Wolfe
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

8.  Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival.

Authors:  James M Donahue; Francis C Nichols; Zhuo Li; David A Schomas; Mark S Allen; Stephen D Cassivi; Aminah Jatoi; Robert C Miller; Dennis A Wigle; K Robert Shen; Claude Deschamps
Journal:  Ann Thorac Surg       Date:  2009-02       Impact factor: 4.330

9.  Nomogram predicts survival benefit for non- metastatic esophageal cancer patients who underwent preoperative radiotherapy.

Authors:  Kenan Xie; Song Liu; Jianjun Liu
Journal:  Cancer Manag Res       Date:  2018-09-18       Impact factor: 3.989

Review 10.  Diagnosis and treatment of esophageal neoplasms.

Authors:  H Kato
Journal:  Jpn J Cancer Res       Date:  1995-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.